ALD connect will be holding an Externally-Led Patient-Focused Drug Development meeting on Friday, July 22 to inform the Food and Drug Administration, about what it is like to live with ALD.
The event will be open to the public online and free of charge.

For more information:ALD EL-PFDD FAQ